# C16orf78

## Overview
C16orf78 is a gene located on chromosome 16 that encodes the protein known as chromosome 16 open reading frame 78. This protein is currently uncharacterized, meaning its specific functions and roles within cellular processes are not fully understood. However, emerging research suggests that C16orf78 may be involved in various biological pathways, including those related to innate immunity and spermatogenesis, as well as potential interactions with zinc finger transcription factors, which are crucial for gene regulation (Fudulu2024Exploring; Varela2021Evolutionary). The gene has also been implicated in cancer prognosis, with its expression levels serving as a potential biomarker for disease-free and overall survival in certain cancers (Ershov2023Uncharacterized). Despite these insights, further studies are necessary to fully elucidate the functional roles and clinical significance of C16orf78.

## Clinical Significance
C16orf78 has been studied for its potential prognostic significance in various cancers. In pancreatic adenocarcinoma (PAAD) and uterine corpus endometrial carcinoma (UCEC), low expression levels of C16orf78 are associated with unfavorable disease-free survival (DFS) and overall survival (OS), indicating its critical role in prognosis (Ershov2023Uncharacterized). The gene is part of a panel of seven genes whose exclusion from analysis significantly decreases the prognostic significance of the remaining genes, underscoring its importance in cancer prognosis (Ershov2023Uncharacterized).

Research also suggests that C16orf78 may be involved in immune cell infiltration and responses to chemotherapy, although specific mutations in the gene and their direct clinical significance are not detailed (Ershov2023Uncharacterized). In colon cancer, the prognostic significance of C16orf78 remains to be further studied, but it is listed among genes of interest in relation to immune cell infiltration in the tumor microenvironment (Ouyang2023An).

While C16orf78 is included in a 4.1-Mb deletion associated with Townes-Brocks syndrome, its specific clinical significance in this context is not highlighted, as the focus is on broader genetic findings related to heart defects and syndromes (Reuter2020The).

## Interactions
C16orf78 is a protein encoded by a gene located on chromosome 16. The interactions of C16orf78 with other proteins or nucleic acids are not well-documented, and its role in multiprotein complexes or transient interactions remains largely unexplored. However, some studies have suggested potential interactions that may be relevant to its function.

C16orf78 is part of a subnetwork involving TMEM63C, which has a direct reciprocal rank ERC association with ACE2, a protein significant in COVID-19 pathologies. This suggests that C16orf78 might be involved in pathways related to innate immunity and spermatogenesis (Varela2021Evolutionary). The protein also forms strong reciprocal rank associations with other proteins such as PAX4, ETS1, and SUV39H1. ETS1 is known to be involved in cytokine and chemokine processes, while SUV39H1 is linked to chromosome stability, indicating potential roles for C16orf78 in these biological processes (Varela2021Evolutionary).

Additionally, C16orf78 has been identified as having high-ranking motifs for zinc finger transcription factors, which are involved in gene regulation and may affect transcriptional activity through interactions with promoter regions (Fudulu2024Exploring). Despite these findings, further research is needed to fully elucidate the functional partnerships and interactions of C16orf78.


## References


[1. (Ouyang2023An) Yiben Ouyang, Mingqian Yu, Tiange Liu, Mengying Suo, Jingyi Qiao, Liqiang Wang, and Na Li. An activated dendritic-cell-related gene signature indicative of disease prognosis and chemotherapy and immunotherapy response in colon cancer patients. International Journal of Molecular Sciences, 24(21):15959, November 2023. URL: http://dx.doi.org/10.3390/ijms242115959, doi:10.3390/ijms242115959. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms242115959)

[2. (Ershov2023Uncharacterized) Pavel Ershov, Evgeniy Yablokov, Yuri Mezentsev, and Alexis Ivanov. Uncharacterized proteins cxorfx: subinteractome analysis and prognostic significance in cancers. International Journal of Molecular Sciences, 24(12):10190, June 2023. URL: http://dx.doi.org/10.3390/ijms241210190, doi:10.3390/ijms241210190. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241210190)

[3. (Fudulu2024Exploring) Alina Fudulu, Carmen Cristina Diaconu, Iulia Virginia Iancu, Adriana Plesa, Adrian Albulescu, Marinela Bostan, Demetra Gabriela Socolov, Irina Liviana Stoian, Raluca Balan, Gabriela Anton, and Anca Botezatu. Exploring the role of e6 and e7 oncoproteins in cervical oncogenesis through mbd2/3-nurd complex chromatin remodeling. Genes, 15(5):560, April 2024. URL: http://dx.doi.org/10.3390/genes15050560, doi:10.3390/genes15050560. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes15050560)

[4. (Reuter2020The) Miriam S. Reuter, Rajiv R. Chaturvedi, Eriskay Liston, Roozbeh Manshaei, Ritu B. Aul, Sarah Bowdin, Iris Cohn, Meredith Curtis, Priya Dhir, Robin Z. Hayeems, S. Mohsen Hosseini, Reem Khan, Linh G. Ly, Christian R. Marshall, Luc Mertens, John B.A. Okello, Sergio L. Pereira, Akshaya Raajkumar, Mike Seed, Bhooma Thiruvahindrapuram, Stephen W. Scherer, Raymond H. Kim, and Rebekah K. Jobling. The cardiac genome clinic: implementing genome sequencing in pediatric heart disease. Genetics in Medicine, 22(6):1015â€“1024, June 2020. URL: http://dx.doi.org/10.1038/s41436-020-0757-x, doi:10.1038/s41436-020-0757-x. This article has 58 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41436-020-0757-x)

5. (Varela2021Evolutionary) Evolutionary Inference Predicts Novel ACE2 Protein Interactions Relevant to COVID-19 Pathologies. This article has 0 citations.